-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- News & Events
- Releases & Announcements
Releases & Announcements
In the Spotlight
NIH Names Dr. Joni L. Rutter Director of NCATS
NIH ∙ 11/08/2022 ∙ NCATS
Joni Rutter, Ph.D., has been selected as the NCATS director. In her new role, Dr. Rutter will oversee a diverse portfolio of research activities focused on improving the translational process of turning scientific discoveries into health interventions.
November 2022
-
NIH Names Dr. Joni L. Rutter Director of NCATS
NIH ∙ 11/08/2022 ∙ NCATS
October 2022
-
NIH-Supported Study Finds Racial Disparities in Advanced Heart Failure Treatment
NHLBI ∙ 10/19/2022 ∙ CTSA Program -
Tissue Chip Developments: What’s the 411?
NIBIB ∙ 10/04/2022 ∙ CTSA Program, Tissue Chip
September 2022
-
Prenatal Steroid Treatment May Improve Survival, Reduce Complications for Extremely Preterm Infants
NICHD ∙ 09/26/2022 ∙ NCATS -
NIH-Funded Study Shows Sound Sleep Supports Immune Function
NHLBI ∙ 09/21/2022 ∙ CTSA Program -
Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
NIDDK ∙ 09/21/2022 ∙ CTSA Program -
Mount Sinai, NCATS Scientists Uncover a Potential New Path Against Neurological Disease
NCATS ∙ 09/08/2022 ∙ NCATS
August 2022
-
Tiny Antibodies May Provide New Tool to Fight COVID-19
NCATS ∙ 08/30/2022 ∙ NCATS
July 2022
-
Media Advisory: To Find Answers for People on Earth, NIH-Funded Tissue Chips Take Flight
NCATS, NIBIB, NIH ∙ 07/13/2022 ∙ Tissue Chip
June 2022
-
Immune Modulator Drugs Improved Survival for People Hospitalized with COVID-19
NCATS ∙ 06/02/2022 ∙ NCATS
May 2022
-
NIH Announces Antiviral Drug Development Awards
NIH ∙ 05/18/2022 ∙ Division of Preclinical Innovation -
Scientists Identify Characteristics to Better Define Long COVID
NCATS ∙ 05/17/2022 ∙ CTSA Program
April 2022
-
Researchers Create 3-D Model for Rare Neuromuscular Disorders, Setting Stage for Clinical Trial
NCATS ∙ 04/19/2022 ∙ SBIR/STIR, Tissue Chip
March 2022
-
Hydrocortisone Does Not Prevent Lung Complication in Extremely Preterm Infants
NICHD ∙ 03/23/2022 ∙ CTSA Program -
NCATS, Duke Scientists Show Compound’s Novel Effects on Key Brain Chemical in Drug Addiction
NCATS, Duke University ∙ 03/03/2022 ∙ Division of Preclinical Innovation
February 2022
-
NIH-Funded Study Suggests COVID-19 Increases Risk of Pregnancy Complications
NICHD ∙ 02/07/2022 ∙ CTSA Program
January 2022
-
Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients
NCATS, NIH ∙ 01/11/2022 ∙ CTSA Program
- Funding & Notices
-